New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 30, 2014
05:48 EDTPFE, NQStocks with implied volatility movement; NQ PFE
Stocks with implied volatility movement; NQ Mobile (NQ) 174, Pfizer (PFE) 23 according to iVolatility.
News For NQ;PFE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
August 27, 2015
09:26 EDTNQOn The Fly: Pre-market Movers
Subscribe for More Information
07:24 EDTPFEPfizer shares even more compelling after recent weakness, says Piper Jaffray
Subscribe for More Information
06:55 EDTPFEHospira sees merger closing on or about September 3
Hospira (HSP) said in a regulatory filing that on August 21, Hospira and Pfizer (PFE) received clearance from the U.S. FTC, relating to the pending merger of Hospira with Perkins Holding Company, a wholly-owned subsidiary of Pfizer. All required regulatory approvals have now been secured, though the merger remains conditioned upon the expiration of a post-clearance waiting period in one foreign jurisdiction. Hospira expects the merger to close on or about September 3.
August 26, 2015
20:03 EDTNQOn The Fly: After Hours Movers
Subscribe for More Information
18:33 EDTNQNQ Mobile up 56% to $4.75 after entering agreement to sell FL Mobile subsidiary
17:10 EDTNQNQ Mobile enters agreement to sell FL Mobile subsidiary
Subscribe for More Information
17:06 EDTNQNQ Mobile sees Q3 revenue $110.0M-$112.0M, two estimates $118.50M
Subscribe for More Information
17:05 EDTNQNQ Mobile sees FY15 revenue $455.0M-$460.0M, two estimates $449.70M
Subscribe for More Information
17:03 EDTNQNQ Mobile reports Q2 non-GAAP EPS 8c, two estimates 5c
Reports Q2 revenue $102.1M, two estimates $102.00M.
17:00 EDTNQNQ Mobile enters into a binding agreement to sell NationSky
NQ Mobile has entered into legally binding share purchase agreements, which provide for the sale of all of NQ Mobile's interest in the NationSky business, including the entire interest in Beijing NationSky Network Technology, to Hou Shuli, a founder and senior management member of Beijing NationSky, for an aggregate consideration of $80M cash. The NationSky business provides device agnostic managed mobile services, mobile device management services and other mobile SaaS offerings to enterprises. The company's board of directors and audit committee approved the NationSky Agreements and the NationSky Divestment. The NationSky Divestment is expected to close within 60 days.
07:32 EDTPFEPfizer launches Phase 3 trial of targeted therapy for breast cancer patients
Subscribe for More Information
06:16 EDTPFEAlvogen to acquire product portfolio from Pfizer for US market
Subscribe for More Information
August 25, 2015
14:50 EDTNQNQ Mobile volatility elevated into Q2 and outlook
NQ Mobile August weekly call option implied volatility is at 183, September is at 129, October is at 104; compared to its 52-week range of 64 to 200, suggesting large near term price movement into the expected release of Q2 results on August 27.
14:16 EDTPFEMylan launches generic version of Pfizer's Zosyn Injection
Mylan (MYL) announced the U.S. launch of Piperacillin and Tazobactam for Injection USP, 3.375g Single-dose Vials, which is the generic version of Pfizer's (PFE) Zosyn Injection. This product is a combination penicillin-class antibacterial and beta-lactamase inhibitor indicated for the treatment of patients with moderate to severe infections caused by susceptible isolates of certain bacteria. Piperacillin and Tazobactam for Injection USP, 3.375g Single-dose Vials had U.S. sales of approximately $72.1M for the 12 months ending June 30, 2015, according to IMS Health. Mylan's launch of this product adds to the company's growing portfolio of more than 145 injectable products available to patients in the U.S. across a broad array of therapeutic categories including oncology, anti-infectives, anesthesia/pain management and cardiovascular.
August 24, 2015
12:57 EDTPFEFTC requires Pfizer to sell rights to four products as condition of buying Hospira
Subscribe for More Information
08:16 EDTPFEBristol-Myers, Pfizer to present new data on Eliquis at ESC Congress 2015
Bristol-Myers Squibb Company (BMY) and Pfizer Inc. (PFE) announced that 22 abstracts will be presented at the ESC Congress 2015, to be held August 29 to September 2 in London, United Kingdom. The new data reinforce the Alliance's commitment to the ongoing evaluation of Eliquis in both the nonvalvular atrial fibrillation and venous thromboembolism patient populations. In addition, data from the AEGEAN study evaluating adherence among NVAF patients further extends the Alliance's commitment to patient care.
08:01 EDTPFEPfizer receives clearance from FTC for Hospira acquisition
Subscribe for More Information
August 23, 2015
12:35 EDTPFEBiotech firms could see 'billions' in sales from new cancer drugs, Barron's says
Subscribe for More Information
August 21, 2015
08:01 EDTPFEPfizer says two Phase 3 Trumenba studies met primary endpoints
Subscribe for More Information
August 20, 2015
11:24 EDTPFEPfizer says Ibrance application validated by EMA
Subscribe for More Information
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use